Answers are grounded in this paper and cite their sources.
In patients with STEMI with cardiogenic shock, early mechanical support with a microaxial pump reduced the risk of death at 180 days, with the survival benefit persisting up to 10 years despite device-related complications.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The DanGer Shock (Microaxial Flow Pump in Infarct-Related Cardiogenic Shock) 10-year data confirm a durable survival benefit with Impella CP (JNJ Medtech) in ST-segment elevation myocardial infarction–related cardiogenic shock (hazard ratio, 0.7; ~600 additional days alive), which is reflected in...”
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Møller et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: